PAPP, K. A.; MEROLA, J. F.; GOTTLIEB, A. B.; AL., E. Dual neutralization of IL-17A and IL-17F with bimekizumab improves quality of life in patients withmoderate-to-severe plaque psoriasis: results from a Phase 2b study and correlation with clinical response. SKIN The Journal of Cutaneous Medicine, v. 2, p. S92, 17 Dec. 2018.